Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence.

    Washington CH, Radday J, Streit TG, Boyd HA, Beach MJ, Addiss DG, Lovince R, Lovegrove MC, Lafontant JG, Lammie PJ, Hightower AW.

    Filaria J. 2004 May 5;3(1):3.PMID: 15128461 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Longitudinal analysis of the development of filarial infection and antifilarial immunity in a cohort of Haitian children.

    Lammie PJ, Reiss MD, Dimock KA, Streit TG, Roberts JM, Eberhard ML.

    Am J Trop Med Hyg. 1998 Aug;59(2):217-21.PMID: 9715935 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.

    Ramzy RM, El Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, Farid HA, Shannon WD, Weil GJ.

    Lancet. 2006 Mar 25;367(9515):992-9. Erratum in: Lancet. 2006 Jun 17;367(9527):1980. PMID: 16564361 [PubMed - indexed for MEDLINE]Related articles

    4.

    The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity.

    Simonsen PE, Meyrowitsch DW, Mukoko DA, Pedersen EM, Malecela-Lazaro MN, Rwegoshora RT, Ouma JH, Masese N, Jaoko WG, Michael E.

    Am J Trop Med Hyg. 2004 Jan;70(1):63-71.PMID: 14971700 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Assessing transmission of lymphatic filariasis using parasitologic, serologic, and entomologic tools after mass drug administration in American Samoa.

    Mladonicky JM, King JD, Liang JL, Chambers E, Pa'au M, Schmaedick MA, Burkot TR, Bradley M, Lammie PJ.

    Am J Trop Med Hyg. 2009 May;80(5):769-73.PMID: 19407122 [PubMed - indexed for MEDLINE]Related articles

    6.

    The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in papua new Guinea.

    Weil GJ, Kastens W, Susapu M, Laney SJ, Williams SA, King CL, Kazura JW, Bockarie MJ.

    PLoS Negl Trop Dis. 2008 Dec;2(12):e344. Epub 2008 Dec 9.PMID: 19065257 [PubMed - in process]Related articlesFree article

    7.

    The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration.

    de Rochars MB, Kanjilal S, Direny AN, Radday J, Lafontant JG, Mathieu E, Rheingans RD, Haddix AC, Streit TG, Beach MJ, Addiss DG, Lammie PJ.

    Am J Trop Med Hyg. 2005 Nov;73(5):888-94.PMID: 16282299 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs.

    De Rochars MB, Direny AN, Roberts JM, Addiss DG, Radday J, Beach MJ, Streit TG, Dardith D, Lafontant JG, Lammie PJ.

    Am J Trop Med Hyg. 2004 Oct;71(4):466-70.PMID: 15516644 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    PCR and Mosquito dissection as tools to monitor filarial infection levels following mass treatment.

    Goodman DS, Orelus JN, Roberts JM, Lammie PJ, Streit TG.

    Filaria J. 2003 Jul 7;2(1):11.PMID: 12890288 [PubMed - as supplied by publisher]Related articlesFree article

    10.

    Th1-like antifilarial immune responses predominate in antigen-negative persons.

    Dimock KA, Eberhard ML, Lammie PJ.

    Infect Immun. 1996 Aug;64(8):2962-7.PMID: 8757821 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Reduced antifilarial IgG4 responsiveness in a subpopulation of microfilaremic persons.

    Marley SE, Lammie PJ, Eberhard ML, Hightower AW.

    J Infect Dis. 1995 Dec;172(6):1630-3.PMID: 7594734 [PubMed - indexed for MEDLINE]Related articles

    12.

    [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?]

    Chanteau S, Roux JF.

    Bull Soc Pathol Exot. 2008 Jun;101(3):254-60. French. PMID: 18681220 [PubMed - indexed for MEDLINE]Related articles

    13.

    Progression of lymphatic vessel dilatation in the presence of living adult Wuchereria bancrofti.

    Dreyer G, Addiss D, Roberts J, Norões J.

    Trans R Soc Trop Med Hyg. 2002 Mar-Apr;96(2):157-61.PMID: 12055805 [PubMed - indexed for MEDLINE]Related articles

    14.

    Evaluation of the whole blood filariasis ICT test for short-term monitoring after antifilarial treatment.

    Schuetz A, Addiss DG, Eberhard ML, Lammie PJ.

    Am J Trop Med Hyg. 2000 Apr;62(4):502-3.PMID: 11220767 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines.

    Amarillo ML, Belizario VY Jr, Sadiang-Abay JT, Sison SA, Dayag AM.

    Parasit Vectors. 2008 May 27;1(1):14.PMID: 18505577 [PubMed - in process]Related articlesFree article

    16.

    Impact of five annual rounds of mass drug administration with diethylcarbamazine and albendazole on Wuchereria bancrofti infection in American Samoa.

    Liang JL, King JD, Ichimori K, Handzel T, Pa'au M, Lammie PJ.

    Am J Trop Med Hyg. 2008 Jun;78(6):924-8.PMID: 18541771 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Border and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand.

    Bhumiratana A, Koyadun S, Srisuphanunt M, Satitvipawee P, Limpairojn N, Gaewchaiyo G.

    Southeast Asian J Trop Med Public Health. 2005 Mar;36(2):390-407.PMID: 15916046 [PubMed - indexed for MEDLINE]Related articles

    18.

    Evaluation of the program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodologic approach.

    Fraser M, Taleo G, Taleo F, Yaviong J, Amos M, Babu M, Kalkoa M.

    Am J Trop Med Hyg. 2005 Oct;73(4):753-8.PMID: 16222021 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis.

    Burkot TR, Durrheim DN, Melrose WD, Speare R, Ichimori K.

    Filaria J. 2006 Aug 16;5:10.PMID: 16914040 [PubMed]Related articlesFree article

    20.

    Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment.

    Supali T, Djuardi Y, Pfarr KM, Wibowo H, Taylor MJ, Hoerauf A, Houwing-Duistermaat JJ, Yazdanbakhsh M, Sartono E.

    Clin Infect Dis. 2008 May 1;46(9):1385-93.PMID: 18419441 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data